Recent study reveals that the HPV (human papillomavirus) vaccine not only prevents the transmission of the virus that causes cervical cancer, but also helps in deterring genital warts and low-grade cervical growths. The recent findings gave the health official of the United States more reasons to promote HPV vaccination especially to young women and girls.
The virus causes an estimated 500,000 cases of cervical cancer each year worldwide. Genital warts and low-grade cervical growths are estimated to have affected 30 million people annually.
Researchers conducted randomized control trial to 17,622 women, which had been given the vaccine or a placebo over a six-month period. The women were from 24 countries and territories, with age ranges from 16 to 26.
Malmo University in Sweden, Lund University, Joakim Dillner from the department of microbiology and colleagues discovered that the vaccine provided major protection against the warts and tumors in women. Researchers noted that 168 of 7,632 women who have taken the placebo developed cervical growths while the 7,629 vaccinated women only 7 of them have the cervical growths.
Based on the results of the study the researchers were able to conclude that the vaccine gave strong and continuous protection against the different types of warts and low-grade female cervical growth for four years.
The research was made possible through Merck Research Laboratories, a division of Merck & Company, manufacturer of the HPV vaccine Gardasil.
According to Dr. Crumpacker, a professor of medicine at Harvard Medical School in Boston, said in an interview that the research provides useful information because it shows the vaccine can do more than just thwart the virus from spreading.
via healthfinder.gov
No comments:
Post a Comment